ATP6V1E1

V-type proton ATPase subunit E 1 · P36543 · ATP6V1E1 on Sugi Atlas →

0 patent compounds predicted against ATP6V1E1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to ATP6V1E1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
The Possible Efficacy and Safety of Lansoprazole Co-administration With Neoadjuvant Chemotherapy in Women With Breast Cancer PHASE3COMPLETED
BSEP Function Rescue During Childhood Inhereditary Cholestatic Diseases PHASE2/PHASE3WITHDRAWN
Applying Proton Pump Inhibitor to Prevent and Treat Acute Fluctuating Hearing Loss in Patients With SLC26A4 Mutation PHASE2/PHASE3UNKNOWN
Copper Histidine Therapy for Menkes Diseases PHASE1/PHASE2COMPLETED
Natural History Study of ATP1A3-related Disease nanUNKNOWN
Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts nanCOMPLETED
Prescreening Study to Identify Potential Wilson Disease Participants for Gene-Editing Clinical Trial nanACTIVE_NOT_RECRUITING
Genetic Analysis of Patients With Pseudoxanthoma Elasticum nanCOMPLETED
Role for Biochemical Assays and Kayser-Fleischer Rings in Diagnosis of Wilson Disease nanRECRUITING
Establishment of Human Cellular Disease Models for Wilson Disease nanCOMPLETED
Nuclear Myosin VI - a Therapeutic Target in Breast Cancer nanUNKNOWN
Pediatric Cardiomyopathy Mutation Analysis nanRECRUITING
Diagnosis of Primary Ciliary Dyskinesia nanCOMPLETED
Exome Analysis in Hearing Impaired Patients nanUNKNOWN
PCD New Gene Discovery nanCOMPLETED
Identification of New Candidate Genes in Patients With Mitochondrial Disease by High Resolution Chromosome Analysis on DNA Chip nanCOMPLETED
Correlation Between Peri-implantitis and Assumptions of Medications nanCOMPLETED
Genetic Analysis of Hereditary Disorders of Hearing and Balance nanCOMPLETED
Genetic Testing in Detection of Late-Onset Hearing Loss nanCOMPLETED
Phenotypic and Genotypic Studies in Congenital and Early Onset Ataxias nanCOMPLETED
DEFINING THE GENETIC DRIVERS OF ADULT-ONSET CHOLESTATIC LIVER DISEASE nanRECRUITING
Gastrointestinal Dysfunction in Children Affected With Mitochondrial Disorders nanCOMPLETED
Longitudinal Assessment of Atypical Tripeptidyl Peptidase 1 Enzyme Deficiency Patients nanACTIVE_NOT_RECRUITING
Genetic Basis of Non Syndromic Congenital Diaphragmatic Hernia nanCOMPLETED
Signs and Symptoms Associated With Molecular Defects in Genetically Inherited Heart Disease nanCOMPLETED
Genetics of Primary Ciliary Dyskinesia nanCOMPLETED
Natural History of Neuronal Ceroid Lipofuscinosis, Batten's CLN6 Diseae nanACTIVE_NOT_RECRUITING
Haptoglobin Phenotype, Vitamin E and High-density Lipoprotein (HDL) Function in Type 1 Diabetes nanCOMPLETED
the Effect of ABCC2 Genetic Polymorphism on Neurotoxicity in Gastrointestinal Cancer Patients Receiving Oxaliplatin nanUNKNOWN
Whole Exome and Whole Genome Sequencing for Genotyping of Inherited and Congenital Eye Conditions nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a ATP6V1E1 binder may also engage these)

ProteinNameSimilarity
P50518 1.000 P50518 →
Q6PCU2 1.000 Q6PCU2 →
Q4R761 1.000 Q4R761 →
P11019 1.000 P11019 →
P31402 0.996 P31402 →
P54611 0.994 P54611 →
Q32LB7 0.984 Q32LB7 →
Q96A05 0.982 Q96A05 →
Q9C9Z8 0.981 Q9C9Z8 →
Q01278 0.980 Q01278 →
Q9D593 0.979 Q9D593 →
Q95X44 0.978 Q95X44 →
Q9U1G5 0.978 Q9U1G5 →
O94072 0.971 O94072 →
O23948 0.961 O23948 →
Q29G21 0.955 Q29G21 →
P22203 0.954 P22203 →
F4HQD4 0.954 F4HQD4 →
Q5M7J9 0.954 Q5M7J9 →
Q5ZLX2 0.954 Q5ZLX2 →
Q4X0I8 0.954 Q4X0I8 →
Q5AZQ5 0.953 Q5AZQ5 →
P56286 0.953 P56286 →
Q2UF96 0.953 Q2UF96 →
Q8W207 0.953 Q8W207 →
O13687 0.953 O13687 →
P0CAN7 0.952 P0CAN7 →
P45437 0.952 P45437 →
P68102 0.952 P68102 →
Q6ZWX6 0.952 Q6ZWX6 →